Acute myocardial infarction (MI) provokes an inflammatory response in the heart that removes damaged tissues to facilitate repair. However, exaggerated and/or persistent inflammation compromises healing, which may be counteracted by regulatory immune mechanisms. A key regulatory factor in an inflammatory response is the antiinflammatory cytokine IL-10, which can be produced by a number of immune cells including subsets of B lymphocytes. Here, we investigated IL-10-producing B cells in pericardial adipose tissues (PATs) and their role in the healing process following acute MI in mice. We found abundant IL-10-producing B cells in PATs under homeostatic conditions, with the majority of them bearing cell surface CD5 (CD5 + B cells). These cells were detected early in life, maintained a steady presence during adulthood, and resided in fat-associated lymphoid clusters (FALCs). The cytokine IL-33 was preferentially expressed in PATs under homeostatic conditions and contributed to enrichment of IL-10-producing CD5 + B cells in PATs. CD5 + B cells expanded in PATs following MI, and accumulated in the infarcted heart during the resolution of MI-induced inflammation. B cell-specific deletion of IL-10 worsened cardiac function after MI, exacerbated myocardial injury, and delayed resolution of inflammation. These findings reveal a significant contribution of IL-10-producing B cells to the anti-inflammatory mechanism that terminates MI-induced inflammation, and identify these cells as novel therapeutic targets to improve the outcome of MI.
Introduction
Despite advances in prevention and treatment, acute myocardial infarction (MI) remains a leading cause of mortality and morbidity worldwide (1, 2) , highlighting the need for new therapeutic strategies. Acute MI provokes a sterile inflammatory response that centers in the heart and involves primarily the innate branch and to a lesser extent the adaptive branch of the immune system (3) (4) (5) . The early "inflammatory phase" is characterized by recruitment of pro-inflammatory cells and release of pro-inflammatory mediators. Although these events are critical for instigating tissue repair by removing damaged tissues, exaggerated and/or persistent pro-inflammatory reactions exacerbate myocardial injury and contribute to short-and long-term complications (6) (7) (8) . As such, a balanced inflammatory phase and its timely termination move the healing process to the subsequent "proliferative phase" followed by a "maturation phase" when the tissue environment in infarcted hearts transitions to an anti-inflammatory state to promote a reparative process. While recent studies have begun to investigate the underlying mechanisms (9) (10) (11) (12) , much remains to be learned regarding the cells and molecules that regulate the progression of MI-induced inflammation. In this context, several reports have identified a beneficial role of the anti-inflammatory cytokine IL-10 in the outcome of acute MI (13) (14) (15) (16) (17) . However, the cellular sources and downstream targets of this cytokine that collectively provide cardioprotection remain to be defined.
Mature B cells can be classified into B-1 and B-2 cells based on a combination of surface phenotype and functional properties, and each class of B cells is comprised of distinct subsets (18) (19) (20) . B-2 cells are also referred to as conventional B cells and make up the majority of B cells in the primary and secondary lymphoid organs. B-1 cells 6
belong to a group of so-called innate-like B cells that respond well to innate signals such as toll-like receptor ligands and other conserved pathogen-derived molecular patterns (21) . Surface expression of CD5 further distinguishes B-1a (CD5 + ) from B-1b (CD5 -) cells. In addition to their well-known function to produce antibodies, B cells fulfill a number of antibody-independent functions. Among the latter B cell properties is the release of cytokines that in turn regulate inflammation (22, 23) . Subsets of B cells that release either stimulatory or inhibitory cytokines have been identified (22) . Published studies have implicated a pathogenic role of B cell subsets producing pro-inflammatory cytokines in acute MI (24, 25) . While still under debate, the term regulatory B cells has been employed in recent years to describe B cell subsets that modulate inflammation through production of inhibitory cytokines, with IL-10-producing B cells as the best studied subset (26) (27) (28) . Judging by their surface phenotype and response to stimuli, which can resemble either B-1 or B-2 cells, it is likely that IL-10-producing B cells differentiate along the developmental pathway for either the B-1 or the B-2 cell lineages (29, 30) . CD5 + B-1a cells are the main IL-10-producing B cells in the peritoneal cavity (PerC) where subsets of B-1 cells preferentially reside (31, 32) , whereas IL-10producing CD5 + B10 cells phenotypically resemble B-2 cells (33) . We and other investigators recently reported that murine abdominal visceral adipose tissues (VATs) represent another site where B-1 cells preferentially reside. These adipose depots contain a significant pool of IL-10-producing B cells that protect against obesity-induced inflammation, with the majority of them bearing a surface phenotype of B-1a cells (34, 35) . 7
VATs are also present in the thoracic cavity. The adipose depots associated with the heart include epicardial adipose tissues (EATs) located between the myocardium and visceral pericardium (epicardium) or around coronary arteries, and pericardial adipose tissues (PATs) located between the epicardium and parietal pericardium (36) . The presence of significant quantities of both EATs and PATs in humans and large animals has been long recognized (37) (38) (39) . In mice, EATs are scant but not absent, whereas
PATs are readily discernible (39). It has been known that PATs house aggregates of leukocytes (40) (41) (42) . More recently, these anatomical structures have been referred to as fat-associated lymphoid clusters (FALCs) (43) (44) (45) that belong to a group of physiological and inflammation-induced tertiary lymphoid tissues (46, 47) . Detailed analyses of FALCs in murine mesenterium revealed a predominance of B cells, with a large proportion of B-1 cells (44) . In response to peritoneal inflammatory stimuli, FALCs of abdominal VATs drastically expand to support B cell proliferation with a preferential expansion of B-1 cells (44) . Previous studies showed a high density of FALCs in murine PATs under homeostatic conditions (44, 45) . A recent report provided evidence for expansion of these lymphoid tissues following acute MI (25 Our studies further show that these cells play a cardioprotective role after acute MI. 8
Results

PATs house abundant IL-10-producing CD5 + B cells under homeostatic conditions.
We previously reported that IL-10-producing B cells were enriched in the B cell compartment of murine perigonadal VATs. The majority of them displayed a surface phenotype of CD5 + B-1a cells (34) . To assess whether this is reflected in adipose tissues throughout the body, we analyzed a variety of adipose depots, including subcutaneous brown adipose tissues (BATs), subcutaneous white adipose tissues (SATs), and VATs in the two body cavities. We harvested interscapular BATs, inguinal SATs, abdominal (perigonadal, retroperitoneal, and mesenteric) VATs, and thoracic VATs (PATs and periaortic VATs, Figure 1a ) from adult wild-type C57BL/6J (WT B6) mice. We first analyzed B cell subsets in purified stromal vascular fraction cells (SVFs) by flow cytometry, and compared them to cells harvested from PerC (Supplemental Figure 1a ). The results showed that, in comparison to BATs and SATs, all depots of VATs had a higher prevalence of B-1 cells that were split roughly 1:1 between B-1a and B-1b cells (Supplemental Table 1 ). Because CD5 + B cells have a higher propensity of producing IL-10, and because we previously showed that CD5 + B cells made up the majority of IL-10-producing B cells in perigonadal VATs (34), we next quantified CD5 + B cells (Supplemental Figure 1b) . The results showed that the prevalence of CD5 + B cells was significantly higher in depots of VATs than those in BATs or SATs (Figure 1b ). The highest frequency (Figure 1b ), together with a large B cell compartment (Supplemental Table 1 ), translated into a strikingly higher density of CD5 + B cells in PATs as compared with perigonadal VATs (Figure 1c ). 9
We next examined IL-10 production, and compared cells harvested from PATs with those from perigonadal VATs. Among B cells freshly isolated from PATs of WT B6 mice, we detected very little IL-10 when comparing mean fluorescence intensity (MFI), and the prevalence of cells expressing high levels of IL-10 (IL-10 hi ) was negligible (Supplemental Figure 2a ). We used cells from IL-10 knockout mice (IL-10 KO) as a control to further ascertain intracellular IL-10. In CD5 + B cells isolated from the two VAT depots of WT B6 mice, IL-10 accumulated to a detectable level after a short-term ex vivo culture in the presence of the protein transport inhibitor monensin. This was reflected by increases in the frequency of IL-10 hi cells (Figure 1d 
CD5 + B cells seed PATs early in life, maintain a steady presence during adulthood, and reside in FALCs.
To investigate the population dynamics of CD5 + B cells in PATs, we analyzed WT B6 mice at different ages. In PATs, CD5 + B cells were detected at the highest frequency when mice were 3 weeks of age. The prevalence of these cells gradually decreased as mice matured to reach steady-state levels (Figure 2a ). The age-dependent population dynamics of CD5 + B cells appeared depot-specific. Seeding of CD5 + B cells in perigonadal VATs lagged behind PATs. The prevalence of these cells in perigonadal
VATs increased as mice matured to reach steady-state levels during adulthood ( Figure   2a ). The prevalence of CD5 + B cells in thoracic periaortic VATs followed the pattern observed for perigonadal VATs whereas the frequency of these cells in PerC resembled the one found in PATs (Supplemental Fig. 4 ).
We next examined the tissue residence of CD5 + B cells in PATs. We prepared whole-mount PATs together with pericardium (see Figure 1a ) and stained the tissues 
Preferential expression of IL-33 in PATs contributes to the enrichment of and IL-10 production by CD5 + B cells under homeostatic conditions.
To investigate the mechanisms involved in the enrichment of and IL-10 production by CD5 + B cells in PATs, we examined the influence of the cardioprotective cytokine IL-33 (52, 53) , which has been shown to influence B-1 cells (45, 54) . Binding of IL-33 with the membrane-bound receptor ST2 (ST2L) transduces signals in target cells, whereas sequestration of this cytokine by secreted soluble ST2 (sST2) blocks its effects (52) . In WT B6 mice, the expression of IL-33 was significantly higher and expression of ST2
isoforms was significantly lower in PATs compared to perigonadal VATs (Figure 4a ). To ascertain whether the IL-33/ST2L signaling axis indeed influenced CD5 + B in PATs, we utilized mouse models of IL-33-or ST2-deficiency (55, 56). IL-33-deficiency (IL-33 KO)
in mice caused disturbances in the subset distribution of B cells in PATs under homeostatic conditions, with significant decreases in B-1a cells (Supplemental Figure   8a ). Consequently, the prevalence of CD5 + B cells was significantly reduced (Figure 4b ). 13
The results for ST2-deficient (ST2 KO) mice were consistent with those for IL-33 KO mice ( Figure 4d , and Supplemental Figure 8b ). IL-10 production in the remaining CD5 + B cells was significantly lower in both IL-33-and ST2-deficient mice (Figure 4 , c and e).
These results indicate that locally produced IL-33 acts through ST2 to enhance CD5 + B cells in PATs under homeostatic conditions.
CD5 + B cells expand in PATs following acute MI and accumulate in infarcted hearts during the resolution phase of MI-induced inflammation.
To assess the response of CD5 + B cells during acute MI, we employed a mouse model of acute MI by surgically ligating the left anterior descending coronary artery (LAD) (57) .
Similar to human pathology, such manipulation provokes an inflammatory response in the heart (3) (4) (5) . We performed a sham or MI procedure on WT B6 mice, and analyzed Table 1 ). The prevalence of B-1 cells, in particular B-1a cells, was significantly lower (Supplemental Figure 10a and Supplemental Table 1 ). Lastly, we examined IL-10 production. Similar to PATs under homeostatic conditions, the levels of IL-10 in freshly purified B cells were very low in both PATs and LVs of sham-or MI-operated mice (Supplemental Figure 11 ). However, the response of B cells to additional challenge displayed differential profiles for PATs and LVs. During the resolution phase of MI-induced inflammation, IL-10-producing B cells were significantly reduced in PATs (left panel in Figure 5d ), but significantly increased in LVs of MI-operated mice (left panel in Figure 5e ). The increases in ventricular IL-10producing B cells were largely accounted for by increases in CD5 + B cells (right panel in Figure 5e ). Together, our findings indicate that IL-10-producing CD5 + B cells expand in PATs after MI, and accumulate in infarcted hearts as the MI-induced response makes its transition to create an anti-inflammatory tissue environment.
CD5 + B cells only represented a minor subset of B cells in normal hearts (Supplemental
B cell-specific deficiency of IL-10 worsens cardiac function after MI, exacerbates myocardial injury and delays resolution of inflammation. 15
We next investigated whether IL-10-producing B cells afford cardioprotection during acute MI. Because our studies showed that B-1a cells made up the majority but not the entire pool of adipose IL-10-producing B cells, we employed a loss-of-function model that deleted IL-10 in the B cell compartment. A mixed bone marrow chimera approach has been used for this purpose (59) (60) (61) (62) . We generated B6 mice containing IL-10deficient B cells (B-IL-10 KO) and control mice containing IL-10-sufficient B cells (B-WT). After reconstitution of the transplanted bone marrow, we first confirmed the efficiency of this approach to delete IL-10 in B cells of PATs (Supplemental Figure 12) as well as of other VATs and PerC. We then performed MI surgery on mice from both groups. We employed echocardiography to examine the function of LVs 3 weeks post-MI (63) . The results showed that lack of IL-10 production by B cells worsened LV function. This was reflected by a lower ejection fraction (EF, left panel in Figure 6a ) and a lower fractional shortening (FS, right panel in Figure 6a ), which were calculated from the parameters taken from M-mode images (Supplemental Figure 13 ). Masson's trichrome staining of collagen showed larger scars in the hearts of B-IL-10 KO mice compared to B-WT mice, indicating exacerbated myocardial injury in the former animals ( Figure 6b ).
Acute MI provokes a sequential accumulation of two subsets of monocytes in infarcted hearts (9, 64) . Pro-inflammatory Ly-6C hi monocytes dominate the early phase to promote removal of damaged tissues, whereas accumulation of anti-inflammatory Ly-6C lo monocytes is associated with transition to an anti-inflammatory tissue environment at the later phases. We therefore analyzed monocyte subsets in the infarcted LVs of B-WT and B-IL-10 KO mice. We employed a flow cytometry strategy (64) that was used in 16
our previous studies on VATs (34) . This analysis separates monocytes from other myeloid cells and further specifies the 2 subsets of monocytes. The results showed that influx of Ly-6C hi monocytes (lower right quadrants in Supplemental Figure 14 ) was comparable between the two groups at 3 days post-MI (Figure 6c, upper left panel) .
This suggests that lack of IL-10 production by B cells does not impair the acute MIinduced pro-inflammatory response. However, the clearance of these cells was significantly delayed in B-IL-10 KO mice, as reflected by a higher prevalence of Ly-6C hi monocytes 10 days post-MI (lower left panel in Figure 6c ). Interestingly, the prevalence Figure 6d ). Collectively, these findings reveal that the presence of IL-10-producing B cells ameliorates the outcome of acute MI.
Discussion
We report here that murine PATs house abundant IL-10-producing CD5 Regardless, our studies show that CD5 + B cells in PATs can function as a source of IL-
10.
It has been reported that subsets of B cells that produce pro-inflammatory cytokines worsen the outcome of acute MI by promoting the early inflammatory phase and the recruitment of pro-inflammatory myeloid cells following MI (24, 25) . Opposing effects of pro-inflammatory and IL-10-producing B cells have been observed for several chronic inflammatory diseases such as obesity (34, 73) . Our studies now extend this concept to the pathophysiology of acute MI. Our findings have shown that IL-10-producing B cells regulate the recruitment of anti-inflammatory monocytes and the clearance of proinflammatory monocytes during the resolution phase post-MI. Additionally, it has been shown that IL-10 influences other downstream cellular targets of hematopoietic and non-hematopoietic origins to collectively improve the outcome of acute MI (15, 16) . PATs are also unclear. Innate lymphoid type 2 cells (ILC2s) are the best-studied IL-33responding cells. In response to IL-33 signaling, these cells release type 2 cytokines such as IL-5 to influence downstream target cells (52) . In addition to ILC2s, several other immune cell types can respond to IL-33 to release type 2 cytokines (52). This includes B-1 cells, in particular B-1b cells (54) . As such, it remains possible that B-1b cells and/or ILC2s in PATs can respond to IL-33 to release type 2 cytokines. The latter might then act on CD5 + B cells, in a manner similar to the response of B-1a cells in PerC (74, 75) . 20
The reported findings place IL-10-producing B cells in the anti-inflammatory response that terminates MI-induced inflammation to facilitate tissue repair. They also expand our understanding of the mechanisms underlying cardioprotection mediated by IL-33. Together, our findings identify IL-10-producing B cells as novel targets to improve the outcome of acute MI. 21
Materials and Methods
Mice. The following mouse strains of both sexes were used for this study. C57BL/6J Other reagents are described below in specific assays.
Cell preparation.
In experiments examining different adipose depots, or PATs and LVs, we harvested and analyzed tissues in parallel from each mouse. Tissues were rinsed in cold PBS, minced to paste-like consistency, and digested by enzyme solutions specified as follows. Adipose tissues were digested with collagenase I as described to yield SVFs (76) . LVs were cleaned under a dissecting microscope, minced, and digested by an enzyme mixture containing collagenase I, collagenase XI, DNase I, and hyaluronidase dissolved in RPMI 1640 medium plus HEPES, as described (64). After digestion, the enzymes were removed by washing 2 times with RPMI 1640 medium containing 5%
FBS. The digestions were then subjected to density centrifugation using Percoll (GE Healthcare Life Sciences) as described previously to purify leukocytes (76) . PerC fluid was collected as described previously (34) . Red blood cells were lysed using ACK buffer (Lonza).
Surface and intracellular staining and flow cytometry.
We performed surface and intracellular antibody staining as previously described (34, 76) . Stained samples were analyzed on a BD FACSCanto II or BD LSR flow cytometer depending on the number of targeted markers. We characterized subsets of B cells and subsets of monocytes as described previously (34, 64) . Intracellular staining of IL-10 was performed as described 23 (34) on either freshly prepared cells or after ex vivo challenge (see below). The acquired data were analyzed using FlowJo software (Tree Star Inc.). In addition to the frequency, we calculated the total number of a cell subset per organ and the number of a cell subset per gram of tissue.
Ex vivo culture of B cells.
We performed ex vivo B cell functional assays to examine the capacity of B cell subsets to produce IL-10 as previously described (34) . Briefly, purified SVFs from VATs or leukocytes from LVs were added into each well of a 96-well round-bottomed tissue culture plate. Cells were cultured for 5 hours in the presence of GolgiStop (BD Biosciences) at 37 0 C in a humidified cell culture incubator with 5% CO 2 .
The un-challenged samples were cultured with GolgiStop alone, and the challenged samples were cultured with GolgiStop plus PIL (50 ng/ml PMA, 500 ng/ml ionomycin, and 10 µg/ml LPS). At the end of culture, cells were harvested for surface and intracellular labeling with antibodies as described above. Immunofluorescence stained slides were cover-slipped using a mounting media containing DAPI (Vector Laboratories) to identify cell nuclei. All images were acquired using a Nikon AZ100M microscope, and viewed using NIH ImageJ software.
Histology and immunostaining of
Parabiosis. We performed parabiosis following a procedure previously described by other investigators (64 Myocardial infarction. We induced acute MI in mice by permanently ligating LAD following a recently developed low-invasive procedure (57) . Briefly, mice were anesthetized with isoflurane (2%). The chest was shaved, and a left thoracotomy was performed in the 4th intercostal space by making a small cut in the skin and bluntly opening the muscle wall. The heart was pushed out of the thoracic space to visualize the left ventricle. For myocardial infarction, the LAD was ligated at a site 3 mm from its origin using 8-0 sutures. For sham controls, no ligation was made. The heart was immediately placed back into the thoracic space followed by closure of the muscle wall.
The skin was then closed with 6-0 sutures. Mice were allowed to recover from anesthesia and were monitored throughout the recovery period. They received subcutaneous injections of buprenorphine every 12 hours for 48 hours, starting 30 minutes before the surgery. 26
Cardiac function and infarct size. Echocardiography under anesthesia was employed
to assess the function of LVs as described (63) SVFs from PATs of mice with the indicated genotypes were examined by flow cytometry 40
for the prevalence of CD5 + B cells. c, e. SVFs from PATs of mice with the indicated genotypes were ex vivo cultured for 5 hours in the presence of monensin, and examined by flow cytometry for IL-10 hi CD5 + B cells (left panels) and the intensity of IL-10 staining in CD5 + B cells (right panels). Summary of 2 independent experiments is shown for b-e (n=9-12 for each group). # : p<0.05; and *: p<0.01 for all panels. 
